Sandeep “Steve” Laumas, M.D.
Dr. Laumas currently serves as the Chief Business Officer and Chief Financial Officer of Instil Bio, Inc. Prior to joining Instil Bio, Dr. Laumas has been actively involved in healthcare investing and serving on company Boards of Directors. He currently serves as a member of the board of directors of BioXcel Therapeutics, Inc. and 9 Meters Biopharma, Inc. He began his career at Goldman Sachs & Co. in New York in the Investment Banking Division. Dr. Laumas then joined Balyasny Asset Management in New York and later moved to North Sound Capital as a Managing Director responsible for global healthcare investments. He has been investing in healthcare via investment vehicles, Bearing Circle Capital. Dr. Laumas has served as a director of Parkway Holdings Ltd. (IHH Healthcare) and SRL Ltd. He has a unique industry perspective, particularly in both public and private investments and financial transactions in the healthcare arena. Dr. Laumas received his A.B. in chemistry from Cornell University in 1990, his M.D. from Albany Medical College, with a research year at the Dana-Farber Cancer Institute and completed his medical internship at the Yale University School of Medicine.